{"filing":{"accession_number":"0001551306-26-000135","cik":"0001551306","ticker":"PGNY","company_name":"Progyny, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"pgny-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155130626000135/pgny-20260806.htm"},"events":[{"id":25810,"run_id":23430,"accession_number":"0001551306-26-000135","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Progyny announced its second quarter 2026 financial results on August 6, 2026, reporting record quarterly revenue of $350.5 million, net income of $28.1 million, and adjusted EBITDA of $62.1 million, along with forward guidance for Q3 and full-year 2026.","company_name":"Progyny, Inc.","ticker":"PGNY","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26733,"accession_number":"0001551306-26-000135","item_number":"2.02","item_title":"Results of Operations and Financial Condition and","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Progyny's second quarter 2026 financial results. The press release announces \"Record Quarterly Revenue, Gross Profit and Adjusted EBITDA\" with specific financial metrics (revenue of $350.5 million, net income of $28.1 million, adjusted EBITDA of $62.1 million) and forward guidance for Q3 and full-year 2026. The disclosure is material as it provides investors with comprehensive quarterly financial performance and outlook information.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:35:32.427395+00:00","company_name":"","ticker":null,"filing_date":""},{"id":26734,"accession_number":"0001551306-26-000135","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Progyny issued a press release on August 6, 2026 announcing its financial results for the fiscal quarter ended June 30, 2026 (Q2 2026), including revenue of $350.5 million, net income of $28.1 million, and adjusted EBITDA of $62.1 million. The disclosure includes detailed financial highlights, key metrics, and forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release furnished under Item 7.01 (Regulation FD Disclosure) with exhibits 99.1 and 99.2.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:35:32.427395+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26733,"accession_number":"0001551306-26-000135","item_number":"2.02","item_title":"Results of Operations and Financial Condition and","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Progyny's second quarter 2026 financial results. The press release announces \"Record Quarterly Revenue, Gross Profit and Adjusted EBITDA\" with specific financial metrics (revenue of $350.5 million, net income of $28.1 million, adjusted EBITDA of $62.1 million) and forward guidance for Q3 and full-year 2026. The disclosure is material as it provides investors with comprehensive quarterly financial performance and outlook information.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:35:32.427395+00:00","company_name":"Progyny, Inc.","ticker":"PGNY","filing_date":"2026-08-06"},{"id":26734,"accession_number":"0001551306-26-000135","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Progyny issued a press release on August 6, 2026 announcing its financial results for the fiscal quarter ended June 30, 2026 (Q2 2026), including revenue of $350.5 million, net income of $28.1 million, and adjusted EBITDA of $62.1 million. The disclosure includes detailed financial highlights, key metrics, and forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release furnished under Item 7.01 (Regulation FD Disclosure) with exhibits 99.1 and 99.2.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:35:32.427395+00:00","company_name":"Progyny, Inc.","ticker":"PGNY","filing_date":"2026-08-06"}]}